Optimization of an Automated Ultrasound Cardiac Guidance Tool

November 10, 2022 updated by: UltraSight
Open-label, single-arm, prospective study. Subjects will undergo one session of 2D Transthoracic Echocardiogram (2D-TTE) ultrasound. The ultrasound will be performed by a trained sonographer.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will use a commercially available handheld imaging device (Philips Lumify transducer).

Primary Objective:

To acquire images of multiple transducer position, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe positions.

Study Type

Observational

Enrollment (Actual)

75

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • Philadelphia, Pennsylvania, United States, 19107
        • Thomas Jefferson University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Up to 75 cardiac patients will be enrolled in this study.

Description

Inclusion Criteria:

  1. Age 18 years and above.
  2. Patients able to understand, read and sign the informed consent
  3. Patient willing to answer a short questionnaire

Exclusion Criteria:

  1. Pregnancy(females of childbearing potential will be tested with a urine pregnancy test prior to their inclusion in the study)
  2. Not willing or not able to sign an inform consent
  3. Physical limitation to maneuvering the probe on the body
  4. Unable to lie flat for study
  5. Patients experiencing a known or suspected acute cardiac event
  6. Patients with severe chest wall abnormalities
  7. Patients who have undergone pneumonectomy
  8. Patients whose anatomy does not lend itself to echocardiography

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ACCURACY- Optimization of an automated ultrasound cardiac guidance tool.
Time Frame: 1 year

To acquire images from different transducer positions, trajectories, and views, at different acoustic windows for capturing images and location relative to body and probe.

This study is designed to capture data for the training of the UltraSight Guidance software AI models. The obtained data will not be anlyzed for statistical purposes but will only be used for the algorithm development based on the technician movements recording, with no reference to images quality or medical utilization.

1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Praveen Mehrotra, MD, Thomas Jefferson University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2021

Primary Completion (Actual)

September 20, 2021

Study Completion (Actual)

September 23, 2022

Study Registration Dates

First Submitted

July 4, 2021

First Submitted That Met QC Criteria

July 24, 2021

First Posted (Actual)

July 29, 2021

Study Record Updates

Last Update Posted (Actual)

November 14, 2022

Last Update Submitted That Met QC Criteria

November 10, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 002-20

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ultrasound Therapy

3
Subscribe